TrialDiabetes, obesity & metabolism2026

First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial.

Ying Jie Chee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.